text:
Autumn's Showiest Flower
Is it a weed or a wildflower? A blessing or a curse? Everyone has an opinion (although only the Grump's is correct), but if you're looking for the showiest blooms of autumn — those which routinely cause multi-car pileups in front of your house due to gawking motorists — here they are.
The name? Helianthus angustifolius aka swamp sunflower or narrowleaf sunflower. Native to the eastern United States, this perennial puts on an autumn show like no other. One reason is that it produces masses of bright yellow blossoms up to 3 inches wide. Another is that in good soil, it can easily grow 8 to 12 feet tall.
Swamp sunflower is blooming right now in the South. The Grump is not alone in his judgment of its impact. Nancy Goodwin, creator of fabled Montrose Gardens in Hillsborough, North Carolina, places it prominently in her border. "When it blooms," she notes, "it's like turning on the lights." Here's a photo from her tropical border taken in late September just as the sunflowers are opening up.
So why do some people hate swamp sunflower? Because it won't stay put. It spreads aggressively by underground rhizomes and will quickly take over a garden if you let it. Plant one plant and next year you'll have 10. The year after that, you'll have 100.
The image below, taken in the Grump's garden, proves the point. I was given a single division some years ago and left it to its own devices. This is what it looks like today on the side of my house.
Beautiful? Yes. Problem? Could be, unless you belong to the Swamp Sunflower Society of America and dream of the day all ugly humans are supplanted by billions of swamp sunflowers.
Fortunately, there are easy ways to control the spread of this plant. For instance:
1. Swamp sunflower plants are easy to pull up and throw away. Just firmly grasp the stem next to the ground and yank. Nothing to it.
2. The wetter the soil is, the faster swamp sunflower spreads. Planting in regular or drier soil slows it down.
Another problem people have is that this plant grows so tall that strong winds and rain can break the stems. But the wise Grump knows how to prevent this. Wait until your swamp sunflowers grow to 4 feet tall and then cut them down to 2 feet. This will probably limit their ultimate height to 6-7 feet, but if that's too tall, cut them back again. Cut them back no later than July, though, so they have time to form lots of flower buds.
Where can you get swamp sunflower? Well, anyone who has it will gladly share some, I promise you. Niche Gardens is a good mail-order source. They offer 'Mellow Yellow' (NOT what you're thinking), featuring soft yellow blooms; and 'Gold Lace,' which grows shorter and spreads less rampantly than the species. Sunlight Gardens is another good source.
What Swamp Sunflower Likes
Light: Full sun
Soil: Moist; lots of organic matter; takes poor drainage
Pests: Powdery mildew
Growth Rate: Fast
Bloom Time: September, October
Where It Grows: Throughout the South, Zones 6 to 10


text:
Rosann Joy Knopp
DeForest, WI/ formerly Plainfield, IL- Rosann Joy Knopp, age 68, passed away peacefully on Thursday, June 20, 2013 after a two year battle with cancer.
She was born on January 3, 1945 in Richland Center, WI, the daughter of Clarence and Doris Grahn. She graduated from nursing school in 1967 and went on to serve as a Registered Nurse until her retirement in 2010.
She met Joseph "Joey" Knopp and they married in 1968. She immediately took on a mothers roll with 3 children and added 2 more. She lived for her family.
She spent many years dedicated to her church volunteering and teaching primary Sabbath school. She loved camping and traveled all over the world but her favorite place was her honeymoon location in Branson, MO. She enjoyed the simple things in life especially cooking, dips & hors d'oeuvres, sewing and gardening.
She spent her recent years volunteering with her sister as the "lunch ladies" at Three Angels Christian School. She gave of herself selflessly and touched so many lives with her love and kindness. She will be dearly missed by all and words cannot express the loss in our hearts.
She is survived by her five children: Mark Knopp, Pamela (Jay) Hilbert, Nancy Parsons, James (Jill) Knopp and Thomas (Joni) Knopp; seven grandchildren: Patrice McKinney, Jack Knopp, Lena and Grant Hilbert, Regan, Ellison and Bryant Knopp; 5 great-grandchildren; five siblings: Larry (Carolyn) Grahn, Loyala Grahn, Cherie Hall, Janie (Ron) Pauls, and Herb (Teresa) Grahn; also many nieces, nephews and other loved ones.
She was preceded in death by her husband of 29 years and her parents.
A memorial service will be held at 1:00 p.m. on Monday, June 24, 2013 at the Madison East Seventh-Day Adventist Church, 910 Femrite Drive, Monona, WI, 53716 with Pastor Titus Naftanaila officiating. Visitation will be held from 12:00 p.m. until the time of service on Monday at the church. Interment will be held at a later date at the Sand Prairie Cemetery in Blue River, WI.
In lieu of flowers, memorials may be made to the Three Angels Christian School, 901 Femrite Drive, Monona, WI 53716.
Special thanks to Cherie, Kyle and Cheli not only for their support and care but for their love, companionship and bringing continued enjoyment to her life. The family would also like to thank Agrace Hospice for their excellent care.
To view and sign this guestbook, please visit www.ryanfuneralservice.com.

subset: commoncrawl


text:
In recent years, there have been many predictions of the downfall of linear television and how technology will have its way with broadcast TV. Over the last decade, we have seen technology chip away at network TV with the rise of services like Netflix, Chromecast, and Amazon Fire. Content is riding high as consumers are able to seek out and binge-watch specific programs, and no longer have to rely on networks to curate shows for primetime around themes like the famous "NBC Thursday Night Comedy Block." Now, consumers can use technology to find and watch shows anywhere, anytime.
We are also seeing the rise of social TV, where consumers are turning to their mobile and tablet devices during programming and commercial breaks to share their thoughts with friends, tweet, or gather extended information about the show and cast. This creates an entirely new avenue for producers to narrate their content and engage consumers, taking the story to a whole new level. Additionally, while these dramas have taken on a life of their own, networks have eliminated movies from their lineups, replacing them with live event-driven reality series like The Voice and Iron Chef. It used to be that only sporting events could amass a scaled audience around a given time, but now every network has the opportunity to create blocks of time that many viewers will not only watch together, but will digitally share with each other, creating a completely new experience for the audience and the advertisers.
In a way, technology is creating a revolution in television like we never thought possible. Technology is poised to take programming to new heights, and I would guess that programming will soon come to a fork in the road. Dramas will evolve into narratives fit for binge-watching and akin to silver-screen experiences, driven by consumers who are willing to pay handsomely for the exact shows they love. On the other hand, live programming will take the place of the cheesy reality show and exhibit well-scripted, socially charged content where the audience is part of the action, possibly controlling the outcome of the event or show. Technology will be used in very different ways to support each of these scenarios.
Where does all of this programming change leave the advertisers? In the TV drama example, more product placement and likely sponsored production development will be embraced even more than it is today. Brands will be so integrated that you may not discern the name of the show from the marketer -"The Walking Dead Brought to You by Hyundai," comes to mind. And in the new reality programs, the audience participates by helping direct the cast, promoting the event live to their friends, and watching flash mobs create buzz for a specific brand.
This dichotomy between live and on-demand programming will indeed create new considerations for marketers to sort out with their media plans. There will need to be much thought given to sponsorship, content production, and real-time buying, which will challenge the upfront model and likely require new dynamic ways for brands to plan and execute their video buys.
Related reading
Attribution, integration and replication: The challenges facing advertisers in the digital age
ClickZ Intelligence presented The State of Digital Advertising 2017 webinar on 27 April 2017 in partnership with Marin Software. What are the challenges currently facing advertisers, and how can these challenges be overcome?
How the whitelisting trend could impact the digital ad market
Advertisers are more concerned than ever about brand safety, and one of the primary ways they're trying to keep their ads from appearing in unfriendly places is through whitelisting. But as more and more brands turn to whitelisting, some are talking about the impact this will have.
How to use Facebook mobile ads as an "interest indicator" to drive conversions
We all know that Facebook is a viable source of huge amounts of mobile traffic with relatively cheap CPCs). It's too good an opportunity to ignore in today's digital landscape - even if your mobile landing-page experience isn't up to snuff.
Seven ways advertisers can deal with brand safety concerns
For years, advertisers have tolerated a big elephant in the room: the fact that their digital ads aren't always appearing where they would want them to.


text:
#1 Ranked Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients' information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children's, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
The Cerebrovascular Surgery and Interventions Center treats arteriovenous malformations of the brain and other cerebrovascular conditions. Arteriovenous malformations (AVMs) are errors in blood vessel development in which tangles of arteries and veins connect abnormally. They can occur in the brain or elsewhere in the body. Brain AVMs are usually present at birth.
Read more on AVMs in other parts of the body.
Brain AVMs often cause no symptoms at all and are discovered during imaging for other reasons. More commonly, though, we see children with AVMs that have caused bleeding in the brain, seizures and other neurological problems. Symptoms may vary depending on the location of the AVM and can include:
In treating brain AVMs, we seek to minimize the child's long-term neurologic risks. In addition to treating the AVM itself, our specialists in neurology, physical/occupational therapy and speech/language therapy address any neurological symptoms that the AVM may have caused.
Before treating a brain AVM, we carefully image it and the surrounding vessels and brain tissue using a variety of noninvasive techniques, each giving different kinds of information. When the AVM is accessible, and there is little danger of interfering with vital brain functions, we attempt to remove it surgically. If the AVM is complex, especially if it involves deep, hard-to-reach vessels, we may recommend endovascular embolization before operating. When the AVM's location in the brain makes direct surgery too risky, and the AVM is small, we may recommend radiosurgery.
The Cerebrovascular Surgery and Interventions Center has pioneered the practice of performing an additional angiogram after treatment, before waking the child from anesthesia, to verify that the entire AVM has been removed. This is important, because even a small portion of an AVM left in the brain can pose a risk of bleeding.
Read more on the Testing & Diagnosis and Treatments pages.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told."


text:
My friend Tiff took some shots of me in front of my subie. I art directed the shoot. I based the shoot after those Japanese tuner magazines, where those old Japanese car tuners go for spirited drive, park, then light up a cigarette and talk about the performance of the vehicle! Yes, I am stupid.
PS - I'm originally from Oregon hence the Oregon hoodie...and wagon!
Critiques welcomed!


text:
Repair door frame
6 Attachment(s)
Dear all,
My door frame has just now been damaged as I had forcibly tried to open it when the door knob got stuck. This led to the damage of the door frame. I am attaching a few pictures. Can you please let me know if there is any way to repair this frame and get it to a decent shape.
Two or three ways to fix that---
First--remove the broken casing on that side of the door--
1. Carefully remove the broken piece if jamb from the broken casing---gkue that into place with Titebond wood glue and clamps--fill with Plastic wood---sand it smooth--
2. Using a Multi-tool or router---carefully remove the brolen section from the stop molding to several inches above and below the break---mill a new piece of wood to fit---glue in place---fill and sand---recut the latch plate---
3, Remove trim from both sides---replace the jamb side and stop molding---recut the catch plate--
Install new casing---
Can I break the piece of wood (that is protruding out) near the latch hole and fill in some kind of glue onto the exposed frame and the broken frame and then bring them together so that they will stick to each other? Also, is there some kind of material like plaster of paris or something like that, which can be used as a filler into the gap in the frame (this gap was formed due to the breaking of the frame and extends from above the latch all the way to the bottom).
How many clamps do you think I might need to hold the two pieces together after sticking the glue?
You have to replace the shattered piece of wood --the casing----that is the trim that is attached to the jamb--the jamb is the part with the lock catch plate.
After you remove the casing---carefully remove the piece of the jamb that is stuck to the casing--
see if it will fit back into the jamb--if so---glue with a good wood glue and clamp it until dry--
3 or four clamps will do---then fill any gaps with wood putty---I like 'Plastic Wood' as it dries hard and sands well---Durhams water putty is another one that is easy to work with--
sand when done--then install a new piece of casing---precut casing sets are available if you don't have a miter saw---
Based on the damage, would you be able to give a rough estimate for costs if I want to
1) do it on my own (considering, I do not have any tools required to finish the job)
2) hire a carpenter to do the repair
Four clamps---$40---glue-$6---plastic wood---$5---sand paper--$5---17 foot of trim--$30--
Caulk--$3--Paint--$10---Nails--$3---About $100---
Carpenter--$65 an hour---plus parts---might be cheaper as the carpenter (trim carpenter) most likely has everything on his truck except the trim and paint.
If it was mine I'd just replace it all with new wood. It will come out looking far smoother, and take less time.
|All times are GMT -5. The time now is 08:28 AM.
vBulletin Security provided by vBSecurity v2.2.2 (Pro) - vBulletin Mods & Addons Copyright © 2017 DragonByte Technologies Ltd.
User Alert System provided by Advanced User Tagging (Pro) - vBulletin Mods & Addons Copyright © 2017 DragonByte Technologies Ltd.


text:
Ex-judge denies theft of blood sample
Page Tools
Former Supreme Court judge Jeff Shaw leaves the hearing yesterday.
Photo: Peter Morris
Former NSW Supreme Court judge Jeff Shaw yesterday denied stealing a sample of his blood destined for a police investigation after he crashed his car.
The Police Integrity Commission is investigating how both halves of Mr Shaw's blood sample taken in hospital - one of which should have gone to police - came into the former judge's possession.
Mr Shaw, the inquiry heard, had a superficial head injury, was unsteady on his feet and smelt of alcohol when he was assessed at Sydney's Royal Prince Alfred Hospital early on October 14. He had earlier been in a minor car crash near his home in Sydney's Birchgrove.
Mr Shaw was the first witness at yesterday's hearing, telling the hearing he had no memory of walking out of the hospital with both blood samples.
Senior counsel assisting the inquiry, Stephen Rushton, put it to Mr Shaw that he had taken the police sample from the hospital.
"That is not true. The only thing I was given was a sealed plastic bag. That's the only thing I took from the hospital," Mr Shaw replied. But Mr Shaw had ended up with both samples, the hearing heard.
The doctor who drew the sample of Mr Shaw's blood said he could no longer remember whether he had placed one half of the sample in a locked police box mounted on a wall.
"I initially thought I'd put it into the box . . . but, on reflection, I think that is more a memory based on routine," said the doctor, whose name has been suppressed.
The blood vial to be given to police, he said, could have been placed on a trolley near Mr Shaw's bed, along with the vial the judge was allowed to keep.
Mr Shaw agreed that his memory of the night of the accident was foggy at best. He had no recollection of the crash, or of checking himself out of hospital not long after arriving.
The commission was told the judge walked out of hospital and took a taxi to his chambers in the NSW Supreme Court about 3am on October 14, staying about an hour.
After calling a nurse at the hospital who had been trying to find him, Mr Shaw eventually went back for further tests.
Mr Shaw's wife of 30 years, Elizabeth Shaw, told the inquiry her husband admitted to her that he had been drinking before the crash. "I asked him if he'd been drinking when he drove the car and he said 'yes'," she said.
Mrs Shaw said she had never asked her husband why he went to work in the middle of the night, and he had never offered an explanation.
She said Mr Shaw seemed pale and distracted when she visited him in hospital and the former judge's memory had become very bad since the accident.
Wife Elizabeth Shaw.
Photo:Dean Sewell
But neighbour Timothy Robertson, a senior lawyer who took Mr Shaw to hospital after the accident, said the judge had seemed lucid when he was with him in hospital. "He was very quiet, even timid I thought at that stage, but he was lucid," Mr Robertson said.
The hospital emergency room nurse who spoke to Mr Shaw at his chambers said the judge became upset when told a sample of blood had already been taken at the hospital. Mr Shaw was not aware, he said, that a sample had already been taken.
The nurse, who cannot be named, also said Mr Shaw had arrived at the hospital smelling strongly of alcohol. "He was unco-ordinated . . . he lost balance a couple of times," he said.
Mr Rushton said the hearing would try to discover how Mr Shaw came to have both portions of the sample. "The focus of these hearings is to find out how that could have occurred. Was it a major stuff-up or something more sinister," he said.
Mr Shaw resigned as a judge last week. The inquiry continues today.


text:
2008-10-03 / Columnists
Historical Views of the Rockaways
F. Hadeler's Haberdashery Establishment, Hammels - 1907
In an old Wave article published in July of 1907, Mr. W.F. Hadeler did state that the well dressed male of the species was known as a "beau brummel" or "macaroni" of a "dandy," and finally that detestable American word known as "dude." "Look prosperous" was Hadeler's motto, and a sign in the store stated so. Also stated was that a man must always look his best for self esteem, and to gain the esteem of businessmen.
Hadeler's store was located on Rockaway Beach Boulevard and Beach 88 Street, where the present Dayton Shopping area parking lot is located, and remained there for many years. Goods were always of top quality!


text:
Item: SWC070
Leg Vein Essentials from Swanson Condition Specific Formulas
Key nutrients combine to offer long-lasting, silky smooth support for beautiful legs
Paraben free
4 fl oz (118 ml) Cream
Featured review
"I bought this supplement because it has horse chestnut in it, along with some other excellent ingredients. Because it works as it claims, I recommend it highly." ~product review by DedieSee all reviews
Ingredients: Purified (deionized) water, Aloe barbadensis (aloe vera) leaf gel, vegetable glycerin, Aesculus hippocastanum (horse chestnut) seed extract, Simmondsia chinensis (jojoba) seed oil, Prunus amygdalus dulcis (sweet almond) oil, extra virgin Cocos nucifera (coconut) oil, stearic acid, cetyl alcohol, beeswax, cocoa butter, shea butter, Ruscus aculeatus (butcher's broom) root extract, Centella asiatica (gotu kola) leaf extract, Glycyrrhiza glabra (licorice) root extract, neem oil, Hypericum perforatum (St. John's wort) whole plant extract, Carthamus tinctorius (safflower) seed oil and Capsicum frutescens fruit extract, Arnica montana flower extract, tea tree oil, lavender oil, Rosmarinus officinalis (rosemary) leaf extract, Citrus grandis (grapefruit) seed extract, phenoxyethanol, d-panthenol (vitamin B-5), vitamin E (tocopherol), vitamin C (ascorbic acid), soy lecithin, potassium hydroxide, xanthan gum, Origanum vulgare (oregano) leaf extract, Thymus vulgaris (thyme) leaf extract, Cinnamomum zeylanicum (cinnamon) bark extract, Rosmarinus officinalis (rosemary) leaf extract, Lavandula angustifolia (lavender) flower extract, Citrus medica limonum (lemon) peel extract, Mentha piperita (peppermint) leaf extract, Hydrastis canadensis (goldenseal) root extract, Olea europaea (olive) leaf extract.
Directions: Smooth cream on clean legs in the morning and at night. For best results, use regularly.
WARNING: For external use only. If redness or irritation occurs, discontinue use. In case of irritation, wash affected area with soap and water. Avoid contact with or near eyes. Do not use on broken skin. Keep out of reach of children.
.37 lbs
Leg Vein Essentials from Swanson Condition Specific Formulas
Key nutrients combine to offer long-lasting, silky smooth support for beautiful legs
Paraben free
Get only the best nutrients for beautiful legs with Leg Vein Essentials from Swanson Condition Specific Formulas. Extracts of butcher's broom, horse chestnut, arnica and gotu kola are blended with moisturizing jojoba oil and aloe vera for long-lasting, silky smooth support. Leg Vein Essentials is paraben free.
"With my personal 100% money-back satisfaction guarantee, you have nothing to lose and great savings to gain."
Lee Swanson, Founder of Swanson Health Products
If you are dissatisfied for any reason, we'll give you a full refund and pay return shipping.
We are dedicated to offering the highest quality products at the best price. Find out more about how we ensure such a high standard in everything we do.Learn More
4 fl oz (118 ml) Cream


text:
by Karen Sampson
New law forbids English video games if French-translation version exists, prompting some to question the motivation behind the "language police."
Government gets their hands dirty
Government involvement in the private sector created a big stir in video game stores in Quebec earlier this year thanks to a new law that has come into effect banning English versions of certain video games. But opponents of the law, the stated purpose of which is to promote the French language, say it could put them out of business. Ronnie Rondeau, a local game store owner who own eight stores in the area, remarked that he feared the worst for his business. "If it really was going to make a difference," he said in an interview in The Star, "I'd be for it, but only a small number of people want to play in French. The rest don't care."
The crowds will go elsewhere
Gamers are notorious for wanting new versions of games as soon as they are released, regardless of the language of the programming. Rondeau says that he even stocks several titles in Japanese becaus demand for the games was so high. But game designers frequently delay the releases of foreign language titles before they can debug the games for fear of future problems. In some cases the game may not be released in Quebec markets at all because the cost of translation isn't worth it for game producers.
Even when games do get released in these limited markets programmers often take multiple extra weeks to release the new games, like the ever popular Rock Band video game. While sales in the United States were soaring over the Christmas holidays sales in Quebec were nonexistent because the game wasn't released in French until six weeks later. Gamers simply looked elsewhere. With government involvement causing some businesses to panic, many have asked whether the Office Québécois de la langue Française, or Quebec's French "language police" have gone too far.
The business of gaming
Gamers have always been known to be a very demanding crowd. Oftentimes games that are delayed even a few days cause the majority of the crowd to look elsewhere, across the border or on the internet, for other options. "I'm afraid it's going to cost me my business," Rondeau said. And even if he is able to scrap it out in the increasingly difficult market, "... money-wise, it's going to hurt."
Karen Sampson writes for Select courses. She welcomes your feedback at Karen.Sampson1120 at gmail.com


text:
|Release Notes and Installation Instructions
|New Hardware Distribution, Version 1.0, July 1999
© 1999 Digital Equipment Corporation
This manual contains release notes and installation instructions for the New Hardware Distribution kit for the Compaq Tru64 UNIX (formerly DIGITAL UNIX) operating system.
COMPAQ, the Compaq logo, and the Digital logo are registered in the U.S. Patent and Trademark Office. Alpha, AlphaServer, NonStop, TruCluster, and Tru64 are trademarks of Compaq Computer Corporation.
Microsoft and Windows NT are registered trademarks of Microsoft Corporation. Intel, Pentium, and Intel Inside are registered trademarks of Intel Corporation. UNIX is a registered trademark and The Open Group is a trademark of The Open Group in the United States and other countries. Other product names mentioned herein may be the trademarks of their respective companies.
Possession, use, or copying of the software described in this publication is authorized only pursuant to a valid written license from Compaq Computer Corporation or an authorized sublicensor.
Compaq Computer Corporation shall not be liable for technical or editorial errors or omissions contained herein. The information in this document is subject to change without notice.


text:
Team USA's Opening Ceremony Uniform for Sochi Has an 'Ugly Christmas Sweater' Vibe
Here's a picture of American hockey superstar Zach Parise looking pretty uncomfortable in his clothes:
[tweet https://twitter.com/TODAYshow/statuses/426346417750167554]
That's the outfit the American delegation will be wearing at the opening ceremony in Sochi. I really like the pants/belt/socks/boot combo, but it'll be hard for people to see them with their eyes drawn to that patriotic-vomit cardigan. It's a similar concept to the snowboarding team's quilt-patched jackets, minus the essential subtlety.


text:
Gameday Boots Women's Texas Tech University Tall Boot
We're sorry, but this particular item has sold out online, so you will not be able to add it to your shopping bag. Please try a different color or size, if applicable.
For the true FAN-atic, kick off any occasion with a pair of Gameday Texas Tech University "Red Raider" boots. Combining contemporary appeal with old-school allure, these handcrafted boots provide both quality and comfort for countless championship seasons to come. Made from the highest quality distressed leather, the embroidered toe, shaft, and heel boasting the Red Raider's most popular markings. "Fight Raiders Fight!" Raiders Fight!"
- 2-in. heel
- Pull-up
- Leather
- Imported
Shipping & Returns
Shipping your purchase is easy on belk.com. Depending on the destination of your package, you can expect it to arrive within 4-7 business days. Shipping Information
Returns are easy on belk.com. Easy returns
More from: Gameday Boots


text:
The Clio is back to show what Renault fine-tuned on the F1 race track
Renault's funky wee Clio is set to make a return to the Kiwi market. The little French-bred hatch was officially sold here last in 2010.
Renault's Ben Montgomery confirmed exclusively to Driven that the Clio would be going on sale in the second half of this year - both in standard family hatch form, and in the Renault Sport RS200 version.
The news comes at an interesting time, with Peugeot distributor Sime Darby recently picking up the Citroen brand. Its Chrysler distribution rights have been given to former Citroen distributor Ateco, which also handles Ferrari and Maserati here.
Industry shuffling aside, the Clio will be competitively priced compared to the last version sold here, which will put it in good stead against small hatches from more than just the other French brands sold here.
"An important part of Renault's growth strategy in NZ will be from the new Clio," says Montgomery. "It also represents a crucial role in defining 'Renault Sport' technology. We have started that process with the fastest front wheel drive, Megane RS265, but the RS200 represents the next logical step.
"Renault are currently providing 36 per cent of the F1 grid with engines and for me these cars are where race meets road."
The RS265 Megane, tested last year by Driven, has won accolades around the world, and the Clio makes a worthy smaller stablemate to the company's line-up.
Standard Clios - which boast dual clutch automatic gearboxes - will be sold with a five-year warranty and the RS version will get three-year coverage. Montgomery promises all Clio models will be competitively priced and well specified "against its Euro competitors. New Clio represents a five-door family car with the glamour of a three-door, and the Clio RS is the natural extension of our Renault Sport range and connects well to our activity in Formula 1.
"In the longer term, there is plenty of opportunity with some of the great new models and concepts we have been seeing from Renault."


text:
The Russian connection: See all our coverage | Read about our investigation
As the Senate's financial reform effort nears the final stretch, there's no mistaking the Obama administration's stance on regulating derivatives, the complex products that derive their value from underlying prices (the cost of wheat, say, or certain stock's value) and are used to both hedge risk and recklessly bet on the economy. Gary Gensler, chairman of the Commodity Futures Trading Commission which oversees derivatives, wants the opaque, $450 trillion over-the-counter derivatives market dragged fully into the open, so price, volume, and the structure of deals is transparent. Ditto Treasury Secretary Neil Wolin, who has said, "We cannot afford to wait to...bring transparency and oversight to derivatives." And Obama himself said last week he'll veto any bill if it lacks tough derivatives regulation. But is Obama and Co. truly doing all it can to back up all that tough talk on derivatives?
That's what one group, the Interfaith Center on Corporate Responsibility, is essentially asking, on the eve of a vote on a major shareholder resolution set to be voted on today by shareholders of Citigroup. ICCR is calling on the US government to flex its shareholder muscle (at 2010's outset, the US government owned 27 percent of Citi) by voting its shares in support of a resolution, filed by ICCR, calling on Citi's board of directors to report on how the bank uses collateral for its derivatives trading and, more importantly, the bank's position on using their customers' money for derivatives trading.
Such a report would shed plenty of light on the bank's derivatives policies, ICCR says, and would align with the calls for greater transparency from the White House, Treasury, and many lawmakers in Congress. "To adopt an inconsistent posture at this critical juncture on derivatives disclosure would be disastrous," says ICCR executive director Laura Berry, "both in terms of how Wall Street reads the signals from Washington and how seriously Congress sees the Obama administration as being in its support of vital financial services reform."
Unlike most bailed-out banks which have bought back their shares, the US government—and by extension the American taxpayer—still owns a significant chunk of Citi. Granted, the US' ownership in Citi has begun to dwindle, as the Treasury announced plans in March to sell off its stake throughout 2010. Still, nowhere near all of those stocks are sold. If the US government voted in favor of the resolution, it could provide some major heft to the broader calls for greater disclosure and regulation of derivatives.
At the moment, the signs suggest that "yes" vote is unlikely. The Treasury, which orchestrated the bailout, has consistently taken a hands-off stance regarding its stock holdings, and a Treasury spokeswoman, Meg Reilly, told Mother Jones yesterday that the department had no comment. Even in the resolution passes without the US government's help, it'd be a major victory for those trying to bring some sunshine to an insanely lucrative and wholly unregulated corner of our financial markets.


text:
ED Magedson – Founder
Ripoff Report
Alpha Master HostingInternet USA
Alpha Master Hosting "Unlimited Webhosting" packages sold via Ebay Internet
Does your business have a bad reputation?
Fix it the right way.
Corporate Advocacy Program™
Dear xxxxxxxx xxxxxxxxx,
We have received your order and will be processing it shortly. The details of the order are below:
Order Number: 2742945xxx
Product/Service: Shared Hosting - Shared Hosting
Domain: xxxx.com
First Payment Amount: $0.00 USD
Recurring Amount: $10.00 USD
Billing Cycle: Annually
Total Due Today: $0.00 USD
Looks great doesn't it. Especially when its sitting on Ebay, using a domain with no visible TOS listed anywheres. Confining myself to behaving on their server, and only installing a script they provide themselves thru Fantastico. My website was up for months problem free, without hassle. Woke up today, with nothing changed or modified. Instantly kicked from their server with this claim:
Dear xxxxxxxxx xxxxxxxxxxx,
This is a notification that your service has now been suspended. The details of this suspension are below:
Product/Service: Shared Hosting
Domain: xxxxxxxx.com
Amount: $10.00 USD
Due Date: 03/21/2015
Suspension Reason: violation of TOS - Where the primary purpose is to sell or to drive traffic to other websites
Please contact us as soon as possible to get your service reactivated.
This website has been up and sold several orders of traffic provided from an external source (not autosurf, actually prime expired domain traffic that was genre and country specific provided from an established wholesale online). Upon seeing this and realizing we've just past our 10,000th visitor. I decided to do some digging.
First flag, there is no TOS listed anywheres. Its a straight portal link and nothing else.
Second flag, it came from Ebay (Yeah you defnitly get what you pay for there)
Third flag, theres never any staff working, its like someone barely sees over it and just stops in to cause drama.
I don't expect my money back, its 10$, i tip more than that. However when it comes down to ripping people off for no reason, promising several things and banning people out of jealousy that they make more from their websites than yours, you gotta say something to the people.
The server itself is buggy, i got tonnes of timeouts. FTP constantly craps up. Takes way to long to get in touch with anyone. There is no live support. Its basically someones basement blade server, and its got his koolaid and cookies sitting on it.
This report was posted on Ripoff Report on 06/21/2014 08:36 AM and is a permanent record located here: http://www.ripoffreport.com/reports/alpha-master-hosting/internet/alpha-master-hosting-unlimited-webhosting-packages-sold-via-ebay-internet-1156471. The posting time indicated is Arizona local time. Arizona does not observe daylight savings so the post time may be Mountain or Pacific depending on the time of year.
Ripoff Report has an exclusive license to this report. It may not be copied without the written permission of Ripoff Report. READ: Foreign websites steal our content
Click Here to read other Ripoff Reports on Alpha Master Hosting
If you would like to see more Rip-off Reports on this company/individual, search here:Search Tips
In order to assure the best results in your search:
Advertisers above have met our
strict standards for business conduct.


text:
|Publication number
|Publication type
|Application number
|PCT number
|Publication date
|Jul 20, 1993
|Filing date
|Dec 12, 1986
|Priority date
|Dec 19, 1985
|Fee status
|Publication number
|Heinrich Pins, Christiane Schmitz
|Original Assignee
|Capsoid Pharma Gmbh
|Export Citation
|BiBTeX, EndNote, RefMan
|Patent Citations (20), Referenced by (102), Classifications (12), Legal Events (3)
|External Links: USPTO, USPTO Assignment, Espacenet
This is a continuation of application Ser. No. 111,790, filed Sep. 9, 1987, now abandoned.
The invention relates to a process for producing individually dosed administration forms, in which a formulation material containing active agents which are plastic at elevated temperature and conventional additives is placed on a stationary or moving substrate or in blisters or cavities produced from films and as a result the formulation material is transferred, accompanied by cooling, into an administration form, as well as to the administration forms obtainable by this process.
The conventional, widely used, solid administration forms for the administration of medicaments, dietetics and the like are essentially tablets, dragees, soft and hard gelatin capsules. These administration forms all require in a first stage shaping and in a second stage product packaging, which must meet the requirements of the product (e.g. stability) and the wishes of the consumer (e.g. attractiveness).
This stepwise production of a product up to the final packaging is disadvantageous from the cost standpoint when it is possible to obtain usable products no longer requiring separate shaping and instead are given their particular shape by the packaging or as a result of the consistency thereof through simple, dosing application to a substrate "run" to the desired shape and are then solidified. If simpler ways are possible, two-stage procedures must be looked upon as disadvantageous.
It could be assumed that processes for filling forms are known and widely used and no longer have any novelty value. As will be shown hereinafter, the patent literature contains information on this subject, which also applies to the pharmaceutical field.
DE-AS 1 017 322 describes a process in which use is made of a combined mould and pack for moulding and despatching ready for sale and use blanks of medicaments and similar materials, such as suppositories, pastilles and the like. However, two or more hinged-interconnected mould parts are required, each of which must have more than half the thickness of the subsequent moulded part to be effective in the sense of the known proposal. It is not possible to separate a packed individual dose.
The entire length of the sliding cover must be removed from the pack to permit the requisite folding apart of the mould parts for removing the shaped blanks. This necessarily leads to a contamination of the fragments which have remained in the pack due to dirt and microorganisms. DE-AS 1 017 322 also mentions the filling of the mould parts with the aid of a moulding frame, which is intended to permit a filling of the mould up to the edge. Material which projects and then solidifies after moulding can be scraped off and reused. This filling process cannot be pharmaceutically relevant as a result of its dosing inaccuracy, because the medicaments resulting therefrom would not meet present day demands.
The same applies with regards to the proposal for producing packaged administration forms according to German patent 1 947 684. This proposal constitutes a further development of the prior art of DE-AS 1 017 322, in that the aforementioned moulding frame is replaced by a perforated film, which is intended to ensure cleaner filling of the individual moulds. Here again it is a complex, discontinuous and hygenically dubious procedure, which cannot therefore be satisfactory.
The procedure of moulding fat-containing materials has been further developed in the meantime. Thus, for some time, separatable hollow forms or cavities preshaped from films have been filled with melted suppository material. After passing through a cooling tunnel, the previously open form is sealed. Approximately 25,000 suppositories per hour can be produced by using costly, automated machines. It is a disadvantageous of this process, which is limited to fats with melting points below 40� C., that solid substances may sediment during the moulding and cooling process due to the low viscosity of the melted fat. Another danger is constituted by the change to the physical parameters of the fats used due to melting and recooling. There can be melting point changes and the moulded articles may be brittle.
Attempts have been made to transfer the knowledge acquired in connection with the moulding of suppositories to orally administrable dosage forms. Thus, DE-OS 27 10 307 describes a process for producing and packaging solid pharmaceutical dosage units, which are produced in tablet form in that the mixture is applied to a continuously moving belt made from a different material and which has tablet-like depressions. The carrier substance can be constituted by fats, fatty mixtures, as well as other lipoid substances and components, whose melting point is above 37� C. and preferably above 43� C. The important statement of DE-OS 27 10 307 for the purposes of the present invention is in the sentence that the melted mixture of carrier substance and active component is "poured" into the depressions with or without a measuring device. This can only mean that it is a low-viscosity, liquified substance mixture which can still be poured, whilst the risk of sedimentation of solids is inherent therein and leads to limitations with respect to the carrier substances used.
The description of the process of DE-OS 27 10 307 does not extend beyond the use of relatively low-melting fats and waxes, which can serve as a matrix for the active substance or substances. It is left open as to how these products can be removed without breaking from the depressions of the foils, how they taste as fats and what release rates are to be expected. At least no product is as yet known which has achieved market success.
The knowledge of the aforementioned patent literature and related publications reveals that the results have not been satisfactory. Firstly the use of carrier substances is limited to those materials which, as fats or waxes, have a relatively low melting point and secondly the introduction of the material into the moulds is limited to pouring processes.
On the basis of this prior art, the problem of the present invention is to so further develop the same that it is possible to process other, more advantageous matrix materials than those described in DE-OS 27 10 307 and which are highly viscous at temperatures above body temperature and supply viscosity values of more than 3000 mPa.s, in a simple and economic manner to high-quality, individually dosed administration forms, without the aforementioned, disadvantageous sedimentation tendency of suspended components.
According to the invention this problem is solved in that the formulation material is based on a sol:gel ratio with a softening range above body temperature and is heated to above body temperature and is dosed with a viscosity of more than 3000 mPa.s under pressure action.
FIG. 1a is a plan view of the product of the present invention, which shows various shapes of the administration forms;
FIG. 1b is a side view of the product of FIG. 1a;
FIG. 2a shows a plan view of a foil with the different administration forms thereon;
FIGS. 2b and 2c show perspective views of administration forms;
FIG. 2d shows a sectional view and FIGS. 2b to 2g show perspective views of the administration forms of FIG. 2a;
FIG. 3a is a plan view of the foil or film with individual cavities;
FIG. 3b is a perspective view of the administration form produced from the respective cavity of FIG. 3a;
FIG. 3c is a sectional view of the administration form produced from another cavity of FIG. 3a;
FIGS. 3d to 3h are perspective views of administration forms extracted from the respective cavities of FIG. 3a; and
FIG. 4 is a schematic view of a filling equipment for making administration forms according to the invention.
Thus, the essence of the invention is that the formulation material to be dosed has a softening point range above body temperature. Thus, the inventively dosed formulation material has the nature of a thermoplastic or plastomer. Thus, these are materials which are essentially not permanently shapeable at normal temperature. Thus, these can be materials which are hard or even brittle at normal temperature, which reversibly soften when heat is supplied and can be mechanically relatively easily shaped, in order to ultimately pass into the state of a viscous material at higher temperatures. It is always necessary to fulfil the requirement of the invention that the formulation material has a softening range above body temperature. It is obvious that this requirement or characteristic of the thermoplastic material is essentially determined by the carrier material to be described in greater detail hereinafter. However, additives, such as plasticizing additives and the like also have an influence thereon. It is a further requirement of the invention that the minimum viscosity of the carrier material is 3000 mPa.s.
However, this viscosity value can be greatly exceeded, e.g. up to more than 50,000 mPa.s or even more than 100,000 mPa.s and can extend up to 500,000 mPa.s.
The process according to the invention can be particularly successfully performed with dosing equipment able to manage viscosities of 500,000 mPa.s, because it is not possible to use simple pumping and pouring processes.
The dosing equipment can in particular be constituted by heatable units operating at high pressure, which have controllable valves, against which the piston or geared pumps build up a uniform high pressure. Through time-precisely limited opening of the valve an always constant quantity of the formulation material to be filled is discharged. Incorporated nozzles or filling needles ensure a clean filling of the hollow forms/cavities and blisters or an exact application to substrates. The pressure under which dosing takes place is generally above 2 bar and is dependent on the viscosity of the heated formulation material to be dosed. It is advantageously between 10 and 70 bar, particularly between 35 and 55 bar.
Basic equipment of the presently described type of filling plants is e.g. supplied in the firms Planatol-Werk or Gerhards-Dosiertechnik and is illustrated by FIG. 4. Essential components of such equipment are a heatable preheating and heating tank 1 from which the warm material to be dosed is brought into heatable high pressure hoses 3 with the aid of geared pumps 2 projecting into the tank and under regulatable pressure and bypass control. The equipment can have one or more outlets for hose connections. There can be a pressure of up to 160 bar in the hoses. The hoses issue into heatable dosing heads 4, which are equipped with spring-mounted ball valves and nozzles 5. By using controlled compressed air valve opening and closing cycles calculated in milliseconds are obtained and as a function of the pressure upstream of the valve the same amount of material is always discharged for the same pressures and opening times. Any cobwebbing of the materials to be processed can be prevented by different nozzle sizes and temperature changes at the dosing heads. In addition to nozzles constructed as injection needles, it is also possible to use conical, double and multiple, as well as surface nozzles. Regulating and control electronics 6 ensure the monitoring and respecting of predetermined pressure and temperature values. By means of synchronizing circuitary the speed of the geared pumps and a belt carrying the forms can be matched to one another.
In order to completely fulfil the purposes of the present invention, modifications are made on the basic equipment, which e.g. make it possible to arrange the injection heads in such a way that there can be several injection shots per form on the forms sliding by. They are also installed in a movable manner, so that it is possible to take charge samples for analytical purposes, e.g. for determining the homogeneity of the charge or the injection shot weight.
As several injection heads are simultaneously used and controlled by a central unit, it is easily possible to fill 100,000 or more forms per hour. A limitation of the output rate is only provided by the mechanical advance of the cavities or forms and each individual nozzle can perform more than 1,000 cycles per minute. Thus, this type of filling system permits a much higher output rate than the equipment hitherto used for the filling of preshaped cavities or forms.
The dosing accuracy of the injection heads can be checked by separate removal from the filling line and separate injection into a weighing dish. For a production rate of 70,000 filled deep drawn cavities per hour with a filling weight of 500 mg, a dosing accuracy <�2% and a relative standard deviation of <1% were found. Laetus equipment, which checks each form for precise filling, can be used for a continual inspection during the filling process. It is also possible to pass the sealed strips over a � balance.
As a result of the above-described inventive procedure, it is possible to process highly concentrated solutions or suspensions of active substances with little carrier substance, whilst filling can still take place with great accuracy. In the case of highly viscous solutions or suspensions, the aforementioned sedimentation tendency is largely eliminated. The filling equipment makes it possible to process materials with viscosities above 500,000 mPa.s. Thus, individual dosage forms of small, space-saving type and which are easy to swallow are obtained.
With the aid of the aforementioned dosing procedure, it is possible to produce dosage forms, which in the simplest case can be injection moulded without any mould on a substrate, either cooled, at ambient temperature or heated to above this and either stationary or in moving form. The viscosity and temperature of the materials to be processed then determine the shape of the desired article. This either leads to flat "lozenges" with a tablet-like appearance or cap-shaped products. If the substrate, e.g. a conveyor belt, is moved during the injection process, then small bars or strips are obtained. By simultaneously moving the spraying head in different directions, e.g. with the aid of an eccentric disk, the most varied product shapes are obtained and which can e.g. assume the shape of internal organs, such as the heart or stomach and in this way can refer to the particular indication range of the product produced. (FIGS. 1a and 1b).
Logically following the inventive principle, a further embodiment of the process proceeds in such a way that blister packs are filled. Blisters or "cupules" are drawn out of foils and films of the most varied type and these are filled and sealed with a cover film or foil, which is generally of coated aluminum. The enclosed formulation material is pressed by the cover foil and is consequently available. This development of the inventive process also makes it possible to produce many different shapes and sizes of the different administration forms (FIGS. 2a to 2g). Appropriately the blisters are given a slightly conical shape to facilitate the pressing out of the product.
The most appropriate use of the inventive process is constituted by the filling of hollow forms or cavities, i.e. forms of any shape and size which are closed all round, except for a feed funnel.
For producing these cavities, it is possible to use essentially all commercially available shapeable and sealable films and foils a, provided that they are compatible with the content to be introduced. Particularly suitable are thermoplastics, such as preferably polyethylene-coated PVC, PP or PVDC films, together with plastic-coated aluminium foils, provided that they can be shaped to the desired hollow form. It is also possible to use papers coated with plastics. Special colours or coatings of the films can make the enclosed product light, moisture or oxidation-proof. The films can be printed or marked in some other way for identifying the product. The term films is intended to cover all materials which can be used for the present purpose of forming hollow forms or cavities from films, i.e. apart from plastic films, also metal foils as well as coated paper and cardboard materials and the like.
Numerous different procedures can be used for producing the cavities. The subsequently described processes only constitute preferred examples. Using moulds, symmetrical or asymmetrical half-cavities can be produced from two films, which have to be welded together in a tight manner at their edges. Initially a funnel-shaped opening remains in the upper part of the cavity and is used for introducing the formulation material. The filling opening is sealed in conventional manner following the filling process and this gives an all round tight pack. Shaping and filling can be performed in such a way that the individual cavities are attached in the form of several "strips", from which the user can separate an individual dose. The product placed in the cavity is exposed by the tearing apart of the films.
In individual cases, it can be particularly advantageous if the films have a small, unsealed area, in which one film projects over the other by a few millimeters. This overlap makes it easier to separate the films.
The individual cavities can e.g. be provided with constrictions, which permit a subsequent division, i.e. portioning of the product, e.g. for a child's dose or portions of a solid article for a three times daily dose (FIGS. 3a to 3b).
FIGS. 1a and 1b gives a number of examples for the administration forms or their cavities obtained according to the invention.
The inventive procedure for producing shaped blanks without any mould-dependent shaping and filling of blister packs and preshaped hollow forms is now to be supplemented by a description of the substances and materials, which as formulation materials differ entirely from the known suppository formulations or the materials given in DE-OS 27 10 307. In addition, vital advantages of the invention compared with the known administration forms will be explained.
Whereas the charges for filling suppository forms or those according to DE-OS 27 10 307 are preferably relatively low-melting fats, according to the inventive process suitable substances for basic formulations can e.g. be raw materials belonging to the gel forming agents. In heat, these form sols with water, other solvents and/or plasticizers. Dissolving of the gel forming agents can take place at temperatures above 100� C. Further adjuvants and active substances can be incorporated, generally by kneading into the cooled solution. At ambient temperature, the viscosity is between 50,000 and 800,000 mPa.s.
The articles obtained with the aid of the described dosing equipment are elastic, break-proof and suitable for swallowing, sucking, chewing or for buccal or perlingual application. They do not melt like fats at body temperature and instead decompose or dissolve in the body fluids at a planned varying speed. If water is used for mixing purposes, this can either be left in the formulations or the articles can be dried to a certain moisture content, e.g. in air conditioning cabinets, so that the hardness and elasticity can be controlled.
As a function of the solubility of the adjuvants and active substances, there are differing, controllable releases of the active substances, whilst there can be considerable variations as regards the nature and quantity of the adjuvants. This makes it possible to easily produce articles with a marked retarding action.
A particular administration form obtainable according to the invention are those products which are resistant to the gastric juices. By incorporating into the basic formulations substances or substance mixtures which do not dissolve in gastric juice, or through the exclusive use of such substances or substance mixtures, it is possible to obtain products able to withstand the gastric juice resistance tests given in pharmacopeias.
The inventive administration forms also make it possible to produce products, in which the initial dose and retard form are in one dose. A special example of this is constituted by the soporific chloral hydrate, which is a rapidly, but briefly acting hypnotic. To make it unnecessary for the patient to take this medicament twice or more during the evening or night and so as to permit uniform deep sleep, it is desirable to guarantee a roughly eight hour sleeping period by a single dose during the evening, without there being any hangover effect the following morning. Thus, according to the invention two or three chloral hydrate-containing formulations with different release characteristics are produced and successively injected in superimposed manner into the hollow form or cavity. The product then looks like that of FIG. 3C and the different layers can be made clear e.g. through different colourings of the individual formulations. A further development of this idea is the processing of fundamentally incompatible substance combinations, such as can e.g. occur in vitamin-mineral mixtures. The first injection shot introduces the vitamin formulation, the second a neutral formulation as a protective coating and finally the third shot introduces the mineral formulation giving an identical layer effect to that of FIG. 3C. It is obvious that the basic formulations in this case must coalesce to give a single solid article. It was pointed out hereinbefore that no difficulties arise when arranging the individual injection heads of the filling system for such injection sequences. It is obvious that the information given in connection with the above example is to be considered in general terms, i.e. for producing layered administration forms according to the invention.
Products suitable for buccal or sublingual administration can be produced in many different forms and compositions according to the basic principle of the invention. Thus, for example, spherical bodies with a small surface or elongated strips with a large surface can be shaped. Readily soluble or almost insoluble substances or mixtures can be used for producing the medicament, as a function of the desired residence time in the mouth. An important advantage of the invention is that slimy substances can be processed, which adhere for a long time to the mucous membrane of the mouth and consequently permit close contact with the mucous membranes of the active substance to be applied.
A further possibility of use of the present invention is the production of chewing and sucking articles, whose solubility can fluctuate between fast and "chewing gum-like". It is e.g. possible to embed substances, which are known as mouth and throat disinfectants or astringents, or as breath fresheners. It is also possible to embed in the basic formulation insoluble substances, which have a certain abrasive effect and serve to clean the teeth when chewing. Chewable antacids, which as viscous suspensions are attached to the mucous membrane of the stomach in film-forming manner, constitute a further field of use of the chewing products obtainable according to the invention. In this example the superiority of the administration forms of the present invention become particularly apparent. The hitherto known chewable antacids were constituted by tablets, which disintegrated in crumbling manner during chewing. The individual particles irritate the throat leading to coughing. In the case of the forms according to the invention, a viscous suspension forms in the mouth and which can be swallowed without irritating the mucous membranes.
According to the invention it is also possible to fill emulsions, e.g. of the W/O or O/W type, which decompose in the presence of body juices to finely disposed droplets and consequently facilitate the resorption of oils and fats and substances possibly dissolved therein. Naturally these emulsions must solidify below approximately 40� C. in order to be able to remove them from the cavities.
The invention also makes it possible to add to the dosage forms to be produced substances which are necessary for ensuring or obtaining a special pH or HLB value. The substances can e.g. be buffer mixtures or emulsifiers with a specific HLB value.
Unlike in the case of gelatin capsules, in which the filling with enzymes is problematical, these can easily be processed in the products obtainable according to the invention, because there is no need to use coatings or adjuvants which are attacked by the enzymes and which therefore reduce enzyme activity.
Another advantage of the invention is that the processing of oily substances, normally reserved for soft gelatin capsules, is readily possible by applying the oil to a carrier. This mixture is then injected together with a gel forming agent to give cavities which have no tendency to "bleed" or leak. This makes it possible to also process aqueous solutions, which is not conceivable for hard and soft capsule fillings.
It is not claimed that the above list of possible uses for the inventive administration forms is complete and it can in fact be extended at random. Specific statements are to be considered in general terms in the sense of the invention.
The following substances and representatives of substance classes or carrier materials can be advantageously used for the inventive process and applications: albumins, gelatins, casein, plant proteins, zein, lecithins, agar, gum Arabic, pectins, alginates, xanthan, natural and modified starches, maltodextrin, methyl cellulose, ethyl cellulose, cellulose ether polysaccharides, carboxymethyl celluloses, etherified carboxymethyl celluloses, hydroxypropyl cellulose, hydroxypropylmethyl cellulose phthalate, cellulose acetate phthalate, polyvinylacetate, polyvinylacetate phthalate, polyvinylalcohol, polyvinylpyrrolidone, polyacrylic acid, methacrylic acid and methacrylate polymers, polyethylene glycols, polyoxyethylene-polyoxypropylene polymers (Poloxalcol), triglycerides, partial glyceride mixtures, ethoxylated partial glycerides, long-chain fatty acids and their salts, silicones, colloidal silicic acid, bentonites, etc.
Substances usable as plasticizers are e.g. glycerol, propylene glycol, polyethylene glycols, acetyltributyl citrate, triacetin, dibutyl tartrate, dibutyl phthalate, sorbitol, sorbitan mixtures, glucose syrup, etc.
For reasons of completeness it is pointed out that it is also possible to add to inventively obtainable products additives, such as e.g. opacifiers, dyes, flavours, sweeteners, preservatives and the like.
It is important for the invention that the aforementioned materials are so matched in preparing a formulation material that the adhesion between the solidified formulation material and the internal surface of the hollow form or cavity is reduced to a minimum. In most cases standard thermoplastics and carriers or formulation masses permit a clean separation. However, if this is not possible in individual cases, the invention provides advantageous aids, to which reference will be made hereinafter.
If necessary, it is possible according to the invention to provide the cavities with separating coatings prior to the filling with the formulation material, in order to prevent sticking or adhesion between the film surface and the formulation material or at least reduce it to a minimum. Preferably the formulation material/separating agent pairs have the affinity pairs lipophilic/lipophobic or hydrophilic/hydrophobic. Preferred substances for this purpose are e.g. talc, starches and the like. It is also possible to atomize or spray into the cavity separating agents, such as oils, fats or silicones. Finally such substances can also be applied to the inner wall by using brush-like, rotary tools, which spread within the cavity. The same applies with respect to deep-drawn packs.
It can be advantageous to apply the separating agent to one side of the starting film prior to the removal of the hollow cavity and said prepared side subsequently forms the inner surface of the cavity.
However, the above-described coating procedures also make it possible to apply those coatings to the inner wall of the cavity which do not function as a separating medium, but instead serve as a carrier coating for lubricants or dyes, flavours, sweeteners, preservatives and the like and which inter alia favourably influence the application or administration of the product. This carrier coating is joined to the introduced formulation material and is placed like a jacket round the solid article. This ensures that only the outer coating of the product is e.g. coloured or aromatized, which greatly reduces corrigents, which would otherwise have to be homogeneously distributed in much larger quantities in the complete charge.
The invention clearly leads to many advantages. Thus, it permits the cost-saving and environmentally beneficial production of orally usable administration forms not suffering from the disadvantages referred to hereinbefore. Thus, inexpensive products are made available, which can be readily produced in very large numbers. It is possible to use an almost unlimited number of different formulations for different indications. Inherently incompatible substances can be present in a single administration form without reacting with one another. It is also possible to process side by side and in large numbers adjuvants, such as e.g. solid and liquid substances which influence the solubility of an active agent, so that planned active substance releases are brought about.
The description of the inventive process makes it clear that the obligatory shaping process for many administration forms is rendered superfluous, because the pack simultaneously forms the shaping element. Thus, there are no packaging problems with respect to the supply of the objects to the packaging machines or with respect to dimensional tolerances, such as have been hitherto unavoidable in the case of soft gelatin capsules. There is no possibility of intermixing of "foreign bodies", such as foreign dragees or capsules, such as can occur in the hitherto known processes during production or packaging, because the product is introduced directly in the liquid state into the pack and the filling opening is sealed. By special shaping of the film, form and content, it is possible to exclude confusion with respect to the products.
The invention also makes it possible to process a very large number of substances side by side, i.e. adjuvants or active substances on the one hand, or solid and liquid substances on the other. This can lead to products with a controlled active substance release, as well as to gastric juice-resistant products. It is also possible to produce chewing and sucking articles.
Many of the novel products, to the extent that they are not designed as sucking or gastric juice-resistant products, as they are generally elastic, can be bit and swallowed in small fragments, without it being necessary to subsequently drink a liquid, which is a help in the case of patients having swallowing difficulties or who do not like to take tablets.
The invention also provides many economic advantages. Thus, the separate shaping stage is obviated, which in itself greatly reduces costs compared with known processes. The high output rate of filled and therefore simultaneously packed forms per time unit and the easily installed on-line process controls represent a further cost-saving rationalization. To the extent that the inventive process is also suitable as a substitute for all known conventional capsule production methods, it is possible to obviate the costs for expensive air conditioning plants and installations for recovering solvents. Since, unlike in capsule production, no raw material is wasted (approximately 50% wastage in soft capsule production and approximately 30% in hard capsule production), this also leads to a clear saving. Finally the inventive process can be performed without prejudice to the environment.
The following examples further illustrate the invention.
The most varied types of carriers can be combined in the most varied ways to obtain the different use purposes. The multiplicity of possibilities of the inventive process can only be intimated by the examples.
______________________________________Gelatin 120 g70% sorbitol solution 180 gWater 373 gWater-soluble protein hydrolyzate 600 gSorbic acid 5 gCaramel 12 gMeat extract flavour 10 g 1300 g______________________________________
The gelatin is dissolved in vacuo at 70� C. in the solution of sorbic acid in water. The flavor, caramel, sorbitol solution and protein hydrolyzate are successively incorporated into this solution. The mixture is vented in the heat. At 56� C. and 48 bar, the material is injected or atomized into heaps of in each case 1300 mg on a substrate cooled to 10� C. Drying takes place at 20% relative humidity and ambient temperature until each individual dose weighs 1 090 mg.
______________________________________Decomposed, esterified starch (Emgum) 120 gOxidized wheat starch (Emox) 180 gSugar 50 g75% glucose syrup 175 gWater 200 gChlorhexidine 6 gExtractum Arnicae plv. subt. 10 gCitric acid:sodium citrate 1:1 20 gGinger flavour 7 g 768 g______________________________________
The sugar, glucose syrup and water are heated to 110� C. until a clear solution is obtained. Both starch types are introduced, accompanied by vigorous stirring, into the solution cooled to 70� C. The mixture is briefly heated to 90� C. After cooling again to 70� C., the remaining substances are homogeneously incorporated in the rising order of their weights. At 70� C. and 90 bar and with a dosing head temperature of 85� C., the material is injected into blisters with a tablet-like depression. Each dose contains 750 mg. Sealing takes place with a peel-off film.
______________________________________Cardiac glycoside 0.5 gethoxylated partial glyceride mixture 100.0 gof natural, saturated, even-numberedplant fatty acids (Softigen 767)Polyoxyethylene-polyoxypropylene 700.0 gpolymer (Poloxalcol)Polyethylene glycol 400 (PEG) 199.5 g 1000.0 g______________________________________
Accompanied by moderate stirring, the melted Poloxalcol kept at 60� C. is introduced into the PEG heated to 60� C. The solution of cardiac glycoside in Softigen heated to 45� C. is homogeneously stirred into the first solution. The material cooled to 45� C. is injected in 200 mg quantities at 22 bar into oval cavities cooled to 10� C. The cooled cavities can immediately be sealed.
______________________________________Gelatin 240 gHydroxypropyl-methyl-cellulose 90 gphthalate (HP 55)Water 389 g25% ammonia 21 g85% glycerol 260 g 1000 g______________________________________
The homogeneous powder mixture of gelatin and HP 55 is rapidly introduced, accompanied by stirring, into the mixture of water and ammonia. It is important for all the powder particles to be uniformly wetted. Following a swelling time of 12 minutes at ambient temperature, the crumbly material is melted in vacuo at 90� C. The glycerol heated to 40� C. is stirred into the viscous material obtained. The cooled material is a basic material for a gastric juice-resistant administration form. By dying the material during production, e.g. with erythrosine, it is possible to show that dosed portions are resistant for 2 hours to artificial gastric juice (0.1n HCl) without bleeding, whilst after transfer into a buffer solution (0.2 m Na2 HPO4 solution 773 ml+0.1 m citric acid solution 227 ml; pH 6.8), they dissolve uniformly and without leaving a residue within 26 minutes.
By incorporating filling materials, e.g. corn starch into the basic formulation the gastric juice resistance is retained, whilst the solubility in artificial intestinal juice can be controllably extended to several hours.
______________________________________Gelatin 240 gCellulose-acetate phthalate (CAP) 90 gWater 410 g85% glycerol 260 g 1000 g______________________________________
This formulation is prepared in the same way as example 4 and the behavior of the dosed portions correspond to those of example 4.
______________________________________Polyvinylpyrrolidon (PVP) (Kollidon 30) 50 gOxidized starch (Emox 170) 250 g85% glycerol 250 gWater 230 gMaltodextrin 480 gDiphenhydramine-HCl 10 gFennel-honey flavour 10 g 1280 g______________________________________
The water and glycerol are mixed. The PVP is introduced into the cold solution and stirred until completely dissolved. Accompanied by stirring, the maltodextrin is firstly dissolved in the solution heated to 95� C., followed by the stirring in of the starch, also at 95� C. The diphenhydramine and the flavour are homogeneously incorporated into the mixture cooled to 75� C. The material is filled in 1280 mg portions into blisters at 65� to 70� C. and 95 bar and immediately after the solidification of the material they are sealed with peel-off film.
|Cited Patent
|Filing date
|Publication date
|Oct 4, 1941
|Apr 4, 1944
|Du Pont
|Injection molding of plastics
|Jun 14, 1955
|Apr 30, 1957
|Basf Ag
|Apparatus for manufacturing pellets from fusible materials
|Jul 6, 1954
|Jun 18, 1957
|Feinstein Edward
|Method of forming a confection package
|Oct 16, 1963
|Sep 12, 1967
|Rosin Engineering Company Ltd
|Method and apparatus for forming liquid drops
|Jan 22, 1969
|Sep 28, 1971
|Daniel Machlin
|Injection molding of liquid thermosetting resins
|Oct 2, 1972
|Aug 27, 1974
|T Higuchi
|Method of making a drug-delivery device
|Title not available
|Title not available
|Sep 29, 1953
|Oct 10, 1957
|Akerlund & Rausing Ab
|Kombinierte Giessform und Verpackung
|Jan 28, 1969
|Aug 20, 1970
|Tobler Chocolat Ag
|Synthetic film pack with recesses for choco - late portions
|Sep 20, 1969
|Apr 1, 1971
|Erich Pfanstiel
|Abziehfolie zum Abdecken der Oberflaeche von Giessformen
|Mar 9, 1977
|Sep 15, 1977
|Aco Laekemedel Ab
|Verfahren zur herstellung von verpackung von festen pharmazeutischen dosiseinheiten
|Jun 11, 1977
|Jan 4, 1979
|Theysohn Friedrich Fa
|Injection moulding machine for plastics - with spring loaded ball as non-return valve at plasticiser screw head
|Jul 1, 1982
|May 19, 1983
|Freunt Ind Co Ltd
|Oral pharmaceutical composition
|Aug 18, 1982
|Feb 23, 1984
|Kenneth L Evenstad
|Suppository acting as lubricant, process for the production thereof and use thereof
|Berthold + Sutter
|Title not available
|Title not available
|Title not available
|Title not available
|Title not available
|Citing Patent
|Filing date
|Publication date
|Apr 25, 1994
|Jan 23, 1996
|Mobil Oil Corporation
|Recyclable blister package
|Aug 1, 1997
|Sep 7, 1999
|Lts Lohmann Therapie-Systeme Gmbh
|Water soluble film for oral administration with instant wettability
|Apr 6, 1999
|Jan 23, 2001
|Lts Lohmann Therapie-Systeme Gmbh
|Water soluble film for oral administration with instant wettability
|Aug 2, 2000
|Sep 4, 2001
|Lts Lohmann Therapie-Systeme Gmbh
|Water soluble film for oral administration with instant wettability
|Apr 25, 1997
|Jun 11, 2002
|Astrazeneca Ab
|Feb 23, 1998
|Aug 13, 2002
|Mcneil-Ppc, Inc.
|Chewable product
|Nov 5, 1999
|Apr 22, 2003
|Lavipharm Laboratories Inc.
|Compositions and methods for mucosal delivery
|Jun 5, 2002
|Jul 15, 2003
|Lts Lohmann Therapie-Systeme Ag
|Water soluble film for oral administration with instant wettability
|May 14, 2002
|Mar 23, 2004
|Lts Lohmann Therapie-Systeme Ag
|Water soluble film for oral administration with instant wettability
|Sep 28, 2001
|Jun 1, 2004
|Mcneil-Ppc, Inc.
|Systems, methods and apparatuses for manufacturing dosage forms
|Sep 28, 2001
|Jul 27, 2004
|Mcneil-Ppc, Inc.
|Systems, methods and apparatuses for manufacturing dosage forms
|Sep 28, 2001
|Jan 4, 2005
|Mcneil-Ppc, Inc.
|Apparatus for manufacturing dosage forms
|Mar 21, 2003
|Apr 19, 2005
|Harry S. Sowden
|Method and apparatus for transferring substrates
|Sep 28, 2001
|Jan 3, 2006
|Mcneil-Ppc, Inc.
|Systems, methods and apparatuses for manufacturing dosage forms
|Sep 28, 2001
|Oct 17, 2006
|Mcneil-Ppc, Inc.
|Methods for manufacturing dosage forms
|Feb 19, 2004
|Feb 27, 2007
|Mcneil-Ppc, Inc.
|Systems, methods and apparatuses for manufacturing dosage forms
|Dec 23, 2003
|May 15, 2007
|Mcneil-Ppc, Inc.
|Systems, methods and apparatuses for manufacturing dosage forms
|Jan 28, 2005
|Jul 10, 2007
|Mcneil-Ppc, Inc.
|Method and apparatus for transferring substrates
|Jun 16, 2004
|Nov 20, 2007
|Mcneil-Ppc, Inc.
|Systems, methods and apparatuses for manufacturing dosage forms
|Dec 11, 2003
|Jan 29, 2008
|Omj Ireland Limited
|Systems, methods and apparatuses for manufacturing dosage forms
|Sep 28, 2001
|Jan 29, 2008
|Mcneil-Ppc, Inc.
|Immediate release tablet
|Dec 22, 2003
|Apr 22, 2008
|Mcneil-Ppc, Inc.
|Systems, methods and apparatuses for manufacturing dosage forms
|May 28, 2004
|Feb 23, 2010
|Monosol Rx, Llc
|Polyethylene oxide-based films and drug delivery systems made therefrom
|Sep 28, 2002
|Oct 5, 2010
|Mcneil-Ppc, Inc.
|Composite dosage forms having an inlaid portion
|Apr 14, 2008
|Nov 2, 2010
|Monosol Rx, Llc
|Method of making self-supporting therapeutic active-containing film
|Oct 28, 2003
|Nov 23, 2010
|Mcneil-Ppc, Inc.
|Burst-release polymer composition and dosage forms comprising the same
|Dec 14, 2006
|Mar 22, 2011
|Monosol Rx, Llc
|PH modulated films for delivery of actives
|Sep 28, 2002
|Jun 28, 2011
|Mcneil-Ppc, Inc.
|Modified release dosage forms
|Sep 20, 2007
|Jul 5, 2011
|Monosol Rx, Llc
|Edible water-soluble film containing a foam reducing flavoring agent
|May 5, 2000
|Jul 5, 2011
|Battelle (Memorial Institute)
|Method and apparatus for manufacturing dissolvable tablets
|Feb 24, 2009
|Jul 5, 2011
|Shun-Por Li
|Method of manufacturing modified release dosage forms
|Feb 13, 2003
|Aug 9, 2011
|Weibel Michael K
|Drug dose-form and method of manufacture
|Apr 22, 2008
|Sep 13, 2011
|Monosol Rx, Llc
|Polyethylene oxide-based films and drug delivery systems made therefrom
|Aug 4, 2004
|Feb 14, 2012
|Mcneil-Ppc, Inc.
|Method of coating a dosage form comprising a first medicant
|Aug 7, 2009
|Jul 2, 2013
|Rb Pharmaceuticals Limited
|Sublingual and buccal film compositions
|Sep 28, 2002
|Oct 1, 2013
|Mcneil-Ppc, Inc.
|Modified release dosage forms
|Jul 10, 2007
|Dec 10, 2013
|Monosol Rx, Llc
|Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|Mar 29, 2013
|Feb 18, 2014
|Monosol Rx Llc
|Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|May 13, 2010
|Mar 4, 2014
|Monosol Rx, Llc
|Film compositions for delivery of actives
|Dec 7, 2011
|Mar 18, 2014
|Mcneil-Ppc, Inc.
|Method for manufacturing dosage forms
|Apr 15, 2005
|Mar 18, 2014
|Mcneil-Ppc, Inc.
|Modified release dosage form
|Mar 26, 2009
|Apr 1, 2014
|Monosol Rx, Llc
|Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|Dec 22, 2006
|Jun 24, 2014
|Uppsalagruppen Medical Ab
|Water-soluble films comprising low-viscosity alginates
|Sep 8, 2006
|Jul 1, 2014
|Monosol Rx, Llc
|Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|Feb 5, 2004
|Oct 21, 2014
|Lts Lohmann Therapie-Systeme Ag
|Water soluble film for oral administration with instant wettability
|Aug 23, 2013
|Dec 2, 2014
|Monosol Rx, Llc
|Process for making a film having a substantially uniform distribution of components
|Aug 23, 2013
|Dec 2, 2014
|Monosol Rx, Llc
|Process for manufacturing a resulting multi-layer pharmaceutical film
|Aug 23, 2013
|Dec 9, 2014
|Monosol Rx, Llc
|Process for manufacturing a resulting pharmaceutical film
|Jun 10, 2011
|Mar 10, 2015
|Monosol Rx, Llc
|Nanoparticle film delivery systems
|Aug 23, 2013
|Aug 18, 2015
|Monosol Rx, Llc
|Process for manufacturing a resulting multi-layer pharmaceutical film
|Jul 30, 2013
|Jan 31, 2017
|The Procter & Gamble Company
|Tooth whitening product
|Sep 28, 2001
|Apr 10, 2003
|Sowden Harry S.
|Systems, methods and apparatuses for manufacturing dosage forms
|Sep 28, 2001
|Apr 10, 2003
|Joseph Luber
|Immediate release tablet
|Feb 14, 2002
|Jun 12, 2003
|International Fluidics.
|Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|Sep 28, 2001
|Jul 3, 2003
|Sowden Harry S.
|Systems, methods and apparatuses for manufacturing dosage forms
|Mar 21, 2003
|Nov 27, 2003
|Sowden Harry S.
|Method and apparatus for transferring substrates
|Feb 13, 2003
|Dec 4, 2003
|Weibel Michael K.
|Drug dose-form and method of manufacture
|Sep 28, 2002
|Apr 1, 2004
|Der-Yang Lee
|Modified release dosage forms
|Mar 22, 2002
|Jul 8, 2004
|Coffee Ronald Alan
|Manufacturing dissolvable dosage forms
|Dec 22, 2003
|Jul 15, 2004
|Sowden Harry S.
|Systems, methods and apparatuses for manufacturing dosage forms
|Feb 5, 2004
|Aug 12, 2004
|Zerbe Horst Georg
|Water soluble film for oral administration with instant wettability
|Sep 28, 2002
|Aug 12, 2004
|Der-Yang Lee
|Composite dosage forms having an inlaid portion
|Sep 28, 2002
|Sep 2, 2004
|Bunick Frank J.
|Edible composition and dosage form comprising an edible shell
|Dec 23, 2003
|Sep 9, 2004
|Sowden Harry S.
|Systems, methods and apparatuses for manufacturing dosage forms
|Feb 19, 2004
|Sep 30, 2004
|Sowden Harry S.
|Systems, methods and apparatuses for manufacturing dosage forms
|Sep 28, 2002
|Dec 2, 2004
|Sowden Harry S.
|Fondant-based pharmaceutical composition
|Jan 30, 2004
|Dec 23, 2004
|Monosolrx Llc.
|Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|Sep 28, 2002
|Jan 27, 2005
|Mcnally Gerard P.
|Dosage form containing a confectionery composition
|May 28, 2004
|Feb 17, 2005
|Monosolrx Llc.
|Polyethylene oxide-based films and drug delivery systems made therefrom
|Oct 2, 2003
|Apr 7, 2005
|Anderson Oliver B.
|Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
|Jan 28, 2005
|Jun 16, 2005
|Sowden Harry S.
|Method and apparatus for transferring substrates
|Jan 26, 2005
|Jun 16, 2005
|Sowden Harry S.
|Systems, methods and apparatuses for manufacturing dosage forms
|Jan 13, 2005
|Jul 7, 2005
|Sowden Harry S.
|Systems, methods and apparatuses for manufacturing dosage forms
|Mar 29, 2005
|Aug 25, 2005
|Monosolrx, Llc.
|Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|Jun 21, 2005
|Oct 27, 2005
|Sagel Paul A
|Tooth whitening substances
|Nov 12, 2003
|Feb 16, 2006
|Givaudan Sa
|Edible film containing food acid
|Sep 28, 2005
|Feb 23, 2006
|Monosolrx, Llc.
|Multi-layer films having uniform content
|Jul 22, 2003
|Jul 6, 2006
|Yang Robert K
|Packaging and dispensing of rapid dissolve dosage form
|Jul 11, 2006
|Nov 2, 2006
|Sowden Harry S
|Systems, methods and apparatuses for manufacturing dosage forms
|Jun 22, 2006
|Mar 29, 2007
|Monosolrx, Llc
|Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|Sep 8, 2006
|May 31, 2007
|Monosolrx, Llc.
|Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|Dec 14, 2006
|Jun 28, 2007
|Monosolrx, Llc.
|PH modulated films for delivery of actives
|Dec 5, 2006
|Jul 5, 2007
|Monosoirx, Llc
|Topical film compositions for delivery of actives
|Jan 19, 2007
|Aug 16, 2007
|Monosoirx, Llc.
|Film lined packaging and method of making same
|Feb 13, 2007
|Dec 6, 2007
|Fuisz Richard C
|Polymer-Based Films and Drug Delivery Systems Made Therefrom
|Sep 20, 2007
|Mar 27, 2008
|Fuisz Richard C
|Edible Water-Soluble Film Containing a Foam Reducing Flavoring Agent
|Sep 28, 2007
|Apr 3, 2008
|Pradeep Sanghvi
|Film Embedded Packaging and Method of Making Same
|Apr 22, 2008
|Oct 23, 2008
|Monosol Rx, Llc
|Polyethylene oxide-based films and drug delivery systems made therefrom
|Mar 26, 2009
|Jul 16, 2009
|Monosol Rx, Llc
|Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|Dec 22, 2006
|Sep 3, 2009
|Kjell Stenberg
|Water-Soluable Films Comprising Low-Viscosity Alginates
|Oct 7, 2009
|Jan 28, 2010
|Monosol Rx, Llc
|Ph modulated films for delivery of actives
|May 27, 2010
|Oct 21, 2010
|Battelle Memorial Institute
|Manufacturing Dissolvable Dosage Forms
|Aug 7, 2009
|Feb 10, 2011
|Monosol Rx, Llc
|Sublingual and buccal film compositions
|Aug 7, 2009
|Feb 10, 2011
|Monosol Rx, Llc
|Sublingual and buccal film compositions
|Jun 30, 2000
|Feb 8, 2011
|The Procter & Gamble Company
|Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
|May 5, 2000
|May 14, 2008
|Method and apapratus for preparing dissolvable tablets
|May 5, 2000
|Jul 19, 2006
|Battelle Memorial Institute
|A method and apparatus for manufacturing dissolvable tablets
|May 5, 2000
|Jul 26, 2006
|Battelle Memorial Institute
|A method and apparatus for manufacturing dissolvable tablets
|Apr 25, 1997
|Nov 6, 1997
|Schuckmann Alfred Von
|Apr 25, 1997
|Jan 15, 1998
|Schuckmann Alfred Von
|May 5, 2000
|Nov 16, 2000
|Electrosols Ltd.
|A method and apparatus for manufacturing dissolvable tablets
|Nov 12, 2003
|May 27, 2004
|Givaudan Sa
|Edible film containing food acid
|U.S. Classification
|264/510, 264/5, 264/264, 264/500
|International Classification
|Cooperative Classification
|European Classification
|Nov 18, 1996
|Fee payment
Year of fee payment: 4
|Nov 20, 2000
|Fee payment
Year of fee payment: 8
|Jan 10, 2005
|Fee payment
Year of fee payment: 12


text:
ED Magedson – Founder
Ripoff Report
theestoreonline.com/Internet USA
theestoreonline.com/theestoreonline.com/ Bait and switch Internet
Does your business have a bad reputation?
Fix it the right way.
Corporate Advocacy Program™
This company offers items on line at a lower cost. When an order is placed, you get a phone call suggesting a different item at a little higher cost. The item is described as being like/kind. I went ahead and allowed the swithch based on 100% customer satisfaction. When I received my camera flash, it was not appropriate for my camera as it did not have the same functions as the Nikon SB 700 I originally purchased. I asked for a return shipping label which they said they did not have or provide. IThey indicated they would refund my shipping if I provided my receipts which I did. I have several e-mails indicating they would reimburse yes all I get is the run around for the refund. Buyer beware..poor customer service and salse practices that are unethical. The item was creditied to my account however the shipping return cost is still outstanding after 60 days and multiple e-mails telling me it was being sent.
This report was posted on Ripoff Report on 11/05/2013 02:03 PM and is a permanent record located here: http://www.ripoffreport.com/reports/theestoreonlinecom/internet/theestoreonlinecomtheestoreonlinecom-bait-and-switch-internet-1097148. The posting time indicated is Arizona local time. Arizona does not observe daylight savings so the post time may be Mountain or Pacific depending on the time of year.
Ripoff Report has an exclusive license to this report. It may not be copied without the written permission of Ripoff Report. READ: Foreign websites steal our content
Click Here to read other Ripoff Reports on theestoreonline.com/
If you would like to see more Rip-off Reports on this company/individual, search here:Search Tips
In order to assure the best results in your search:
#1 Author of original report
SUBMITTED: Tuesday, November 05, 2013POSTED: Tuesday, November 05, 2013
The exact same issue by another consumer can be found
at "Nikon Flash". I wonder how may more have been exposed to this scam. Buyer beware.
Are you an owner, employee or ex-employee with either negative or positive information about the company or individual, or can you provide "insider information" on this company?
Advertisers above have met our
strict standards for business conduct.


text:
Amazon.com Review
In a nutshell: Zone One is a story of three days in the life of one Mark Spitz and his squad of three "sweepers" moving through the eponymous Zone One of lower Manhattan, a walled-off enclave scheduled for resettlement in the aftermath of a zombie plague. The great masses of the undead, known as "skels" for their skeleton-like appearance, have been violently dispatched by a Marine detachment. It falls to Spitz and his fellows to take care of the handful that remain, as well as a second-tier of the infected known as "stragglers": zombies who have bypassed the cannibalistic urges of their more lethal fellows in favor of a hollow-eyed, eerily nostalgic repetition of some mundane act. Surfing a vanished web. Switching the channels of a dead remote. Filling helium balloons in a ransacked party supply store. Running a photocopy machine, presumably for all eternity.
These trapped souls, like much in Whitehead's novel, evoke a pure pathos. But Whitehead's tale is as much a chronicle of the living as the dead. Survivorship is his true subject, and with its lower-Manhattan setting, Zone One's suggestive nod to a post-9/11 New York is no accident. Part of the novel's power flows from the reader's uncomfortable sense that Whitehead's apocalypse, for all its strangeness, also feels strangely familiar.
But what truly sets Zone One apart from the literary and filmic zombie hordes is the sheer quality of the writing. Whitehead's language zings and soars. The zombie genre is an intrinsically playful blend of horror and slapstick, but Whitehead takes this maxim to vertiginous new heights, producing a shockingly full-throttle immediacy in the process. The distance between the real world of the reader and the imagined world of Whitehead's skel-infested New York, in all its aching pity and graveyard comedy, collapses to nothing. In these pages, the world of the undead is brought vibrantly to life. Friends, you are there.
Readers of Whitehead's previous novels may be surprised to find him traveling the halls of zombie horror. They shouldn't. For a long time Whitehead has strutted his stuff as one of our smartest young writers, and Zone One is every inch the book he was born to write, a pop-culture thriller of the first order. It will make you think. It will make you want to bar the door and weapon up. It will make you miss the obliterated, lovely world for the duration of its reading, and for some time after. It's that kind of book: a zombie novel with brains.


text:
No Items
There is nothing to display yet, check back soon.
Taylor fan from June of '06 fell in love with her the very first time I heard her voice. I'm a die hard Swift fan for sure I'll walk out in my Taylor shirt and I don't care what anyone has to say about that. I guess being a guy that makes me sort of an oddball Swifty but that's alright with me.
There is nothing to display yet, check back soon.
There is nothing to display yet, check back soon.
Hello there. So I know I messaged you a while back about the "Taylor Reunion" project, but I realized something: just because I messaged you and just because we're on each other's friends list doesn't mean you have any clue who I am or what I am about. So allow me to formerly introduce myself. My name is Vince Favetta. You might know me from one of the many blogs I've written, or you might have gotten a message from me a while back asking you to participate in what became the "Red Lyric Video". Today, however, I am coming to you to talk about a brand new project.
You already know this if you've ever been anywhere near my page or read a single word of stuff I've written, but four years ago I had a chance encounter with Taylor, that, in many ways, changed my life. After all, it was that very event that brought me to Taylor Connect a while back, and so many people here have become so much a part of my life's ever-expanding story. But from the moment I created my very own page, I had a dream. I dreamt that one day I would get the chance to look Taylor in the eye and thank her for all she's done to me. Sure, I could write a letter or just type out a message, but I believe that there are some words that take on a whole new meaning when you look someone in the eye and say them. Things like "Thank you". Things like "I love you". Things like "You changed everything".
With that goal in mind, I began to create a project that would allow all of the Swifites that had become just as much authors in this story to help write the next chapter. To decide whether or not I should get to see Taylor again and thank her. But as the project expanded, as people came in and brought countless ideas to the table, something dawned on me. The project became about the words that lie at the heart of it all. Thank you. We owe so many people so much, and I wanted to give people a chance to say it. I, for one, have found that more often than not we may think the words, but we never actually say them. We never speak now. We love our parents but we don't thank them for the immeasurable acts they do for us. We love our friends but we never thank them for adding untold beauty to our lives every day. We love Taylor, but we never get to thank her for giving us the means to express our deepest selves.
And so, ultimately, The Thank You project has been born. In this very first stage, it has been set to an event page of Facebook, the link to which will be on the bottom of this post. On this page, when you click the "join" button, you are saying to your friends and to the world that you WILL speak now. You won't just keep the words in your head, but you WILL say the seemingly simple words that can change a life for good. Then, use the page and do just that. Thank the people you love. Thank your friends and your family, and tell them all the things you feel. And thank Taylor and her music. Thank her for a song, a lyric. Speak now and say how a lyric or an attitude has done so much for you. Then, invite other to do the same. Share the page on your own personal means of social media, be it Facebook, instagram, Twitter or whatever you use. Being a light in the world is a beautiful thing, but sharing that light with others is a miracle.
So that is what I ask of you. Whether you have read anything I've ever written or have never even heard my name until this message, this is what I ask of you. Join the event, leave your Thanks, and Share the page. Join, Thank and Share. Steps as simple as the words themselves, yet potentially just as powerful. Speak now and let those people know that they are appreciated. That they are cherished. That they are loved. Whether it's the friend you see every day or the artist this site is meant for, every single person deserves to hear the words.
Thank you. As promised, here is the link to the page.
Hey there!
We just wanted to stop by and introduce ourselves and our show to you! We're four Swifties (two of us were previously hosting on Taylor Talk : The Taylor Swift Podcast ) who really love Taylor and have decided to create Swiftcast : A Taylor Swift Podcast By Fans, For Fans so that we could not only support Taylor, but support SWIFTIES as well!
We record and produce our show weekly, and its FREE to subscribe to and download on iTunes! We not only strive to keep you up to date on all the latest things going on with Taylor, but we really want to include YOU in our show as well. We want to hear YOUR opinions, we want to talk about stuff YOU want to hear, we want YOU to participate!
We just released our third episode and we were lucky enough to have gotten an Interview with KEVIN MCGUIRE, so you should definitely check that out if you want to hear all about his incredible Taylor story. He also talks about his incredible fight with lukemia and tells us all how YOU can help by donating bone marrow.
We're doing a LOT of Giveaways on the show, so you can listen to the show and also check out our website to see how YOU can enter to win Taylor Merch, iTunes Gift Cards and more! We're currently still running our Facebook Giveaway, all you have to do is 'Like' us ( www.facebook.com/swiftcast13 ) and you're automatically entered to win a ONE OF A KIND Taylor Swift necklace! Follow us on twitter at @swiftcast13 for lots of updates on our latest Giveaways, special guests, and more!
We want to hear about YOUR fan projects so we can talk about them on the show!! Contact us (all methods of contact are listed on our website) if you're working on a special project you want us to talk about!
Has Taylor inspired you in a really unique way? Email us and tell us about it, we may read your email the show!!
Thanks for reading this! We look forward to getting to know you and we hope you check out the show!!
<13, Ashley, Belle, Emily and Haley
[email protected]
I haven't added this to my profile yet


text:
Date and time:
August 16, 2014, 1:00 p.m. to 2:30 (or 3:00)
Citrus County Library, Coastal Region Branch
8619 W. Crystal St.
Crystal River, FL 34428-4468
Phone: (352) 795-3716
Meeting Details:
We always start out with a couple of easy songs to warm up. After we finish the new songs we'll choose some songs from our 2013 song file or from earlier this year. So bring all previous songs with you.
If you don't have a working printer at home, you can go to any branch location of the library and use one of their computers to print the files. You do have to become a library member (if you aren't already) and printing is 15 cents per page. Or you can use the library's copier to make a copy once you get there, come a little early if you need to do that.
Song List: distributed via email attachment for August
List of things to bring:
- A printout of the pdf file with our songs for the day and bring the all the songs from prior meetings so we can play some of the old ones again.
- Ukulele and your Tuner (If you don't have a ukulele yet, you can come and see what it's all about and learn about the different ukuleles available to choose from.)
- Music Stand (Optional but nice to have. You can use a chair or bring a folding TV table to put your music on.)